Psychometric performance of the PAncreatic CAncer disease impact (PACADI) score

Heiberg, Turid; Baekelandt, Bart Maria Gilbert; Kvien, Tore K; Buanes, Trond

doi:10.1016/j.pan.2019.09.001

Cited by 7 publications

(12 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The total score of PACADI is calculated according to the following algorithm: NRS pain/discomfort value × 0.16 + NRS fatigue value × 0.16 + NRS bowel/digestion value × 0.15 + NRS loss of appetite value × 0.14 + NRS anxiety value × 0.13 + NRS dry mouth value × 0.11 + NRS itchiness value × 0.08 + NRS nausea value × 0.07. 27 The original version of the PACADI score has been demonstrated to have satisfactory internal consistency reliability, test-retest reliability, discriminant validity, concurrent validity, and predictive validity. 27 …”

Section: Methodsmentioning

confidence: 99%

“… 27 The original version of the PACADI score has been demonstrated to have satisfactory internal consistency reliability, test-retest reliability, discriminant validity, concurrent validity, and predictive validity. 27 …”

Section: Methodsmentioning

confidence: 99%

“…Disease-specific scales usually have higher sensitivity than generic scales. 27 Among the multidimensional symptom assessment scales, only two are specifically designed for PC patients. One is a joint instrument composed of the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-Core (EORTC-QLQ-C30) and the EORTC Quality of life Questionnaire-Pancreatic Cancer (QLQ-PAN26), 28 , 29 and the other is the Pancreatic Cancer Disease Impact (PACADI) score.…”

Section: Introductionmentioning

confidence: 99%

“… 30 In addition, the PACADI score has excellent psychometric performance and can even predict the 1-year mortality of PC patients. 27 Furthermore, a PACADI website was established in 2013, and an increasing number of international visitors from the United States, Canada, and Sweden have expressed interest in using the PACADI score for scientific purposes. 27 These strengths make the PACADI an outstanding candidate for foreign language translation and validation in other regions.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Translation and validation of the Pancreatic Cancer Disease Impact score for Chinese patients with pancreatic cancer: A methodological and cross-sectional study

Cui¹,

Yu²,

Sun³

et al. 2023

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Translation and validation of the Pancreatic Cancer Disease Impact score for Chinese patients with pancreatic cancer: A methodological and cross-sectional study

Cui¹,

Yu²,

Sun³

et al. 2023

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

“…Also, PACADI demonstrated a high internal consistency as well as high test–retest reliability. [ 7 ]. As previous studies indicate PACADI to be a reliable and valid questionnaire, there is a rationale to translate it into other languages, such as Swedish, and psychometrically test it in clinical and research practice.…”

Section: Introductionmentioning

confidence: 99%

PACADI: translation and adaptation of a Swedish-language version of the pancreatic cancer disease impact score

et al. 2022

View full text Add to dashboard Cite

Objective The Norwegian pancreatic cancer disease impact score (PACADI) is a digitalized analogue questionnaire that assesses different disease-specific symptoms. There is a need of translations of it into other languages. Therefore, the aim of this article is to describe the translation process of a Swedish version of PACADI and present its validity to EORCT QLQ PAN26. The self-administered questionnaire PACADI was translated according to guidelines and assessed by an expert panel of health care personnel. The test of its validity was performed with the disease-specific questionnaire for EORCT QLQ PAN26. Both questionnaires were completed by 66 subjects with pancreatic cancer, either before, at discharge or three months after surgery. Result The results between the groups indicate that patients suffer from different symptoms at different times. The correlations between the different symptoms of the two questionnaires were fair to good. In conclusion, PACADI and QLQ PAN 26 have a good correlation and PACADI can be used in clinical practise.

show abstract

Happy thus survivor? A systematic review and meta‐analysis on the association between cancer survival and positive states, emotions, and traits

Fontesse,

Fournier,

Gérain

et al. 2023

Psycho-Oncology

View full text Add to dashboard Cite

ObjectivesTraditionally, the literature investigating patient‐reported outcomes in relation to cancer survival focused on negative factors such as distress. Meta‐analyses in this field have provided a clear identification of negative affect that reduce cancer survival (e.g., depression). Nevertheless, positive psychological factors and especially positive affect might be equally crucial for cancer survival but have been neglected so far. While studies in this domain have been conducted, they remain less numerous and have produced mixed results.MethodsA pre‐registered systematic review and meta‐analysis (https://osf.io/jtw7x) aimed at identifying the positive affect linked to mortality in cancers were conducted. Four databases (Pubmed, PsycINFO, Embase, and Cochrane Library) were searched to find longitudinal studies linking positive affect to survival in cancers. Two reviewers completed each stage of the study selection process, the data extraction, and the Quality in Prognosis Studies risk of bias assessments.ResultsTwenty‐four studies involving 822,789 patients were included based on the 2462 references identified. The meta‐analysis reveals that positive affect is associated with longer survival (Hazard Ratio [HR] = 0.91; 95% CI [0.86, 0.96], z = −3.58, p < 0.001) and lower mortality (Odd Ratio [OR] = 0.59; 95% CI [0.45, 0.78], z = −3.70, p < 0.001). Sub‐group analyses indicated that the main predictors of survival are emotional and physical well‐being, optimism, and vitality.ConclusionThis work emphasizes the need to consider the role of affective mechanisms in patients with cancer, including their levels of well‐being or optimism to provide the most favorable conditions for survival. Therefore, stronger and continuous effort to improve patients' positive affect could be particularly beneficial for their life expectancy.

show abstract

Psychometric performance of the PAncreatic CAncer disease impact (PACADI) score

Cited by 7 publications

References 35 publications

Translation and validation of the Pancreatic Cancer Disease Impact score for Chinese patients with pancreatic cancer: A methodological and cross-sectional study

Translation and validation of the Pancreatic Cancer Disease Impact score for Chinese patients with pancreatic cancer: A methodological and cross-sectional study

PACADI: translation and adaptation of a Swedish-language version of the pancreatic cancer disease impact score

Happy thus survivor? A systematic review and meta‐analysis on the association between cancer survival and positive states, emotions, and traits

Contact Info

Product

Resources

About